
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers
Authors' Affiliations: 1 Department of Experimental Surgery and Molecular Oncology, Universitaetsklinikum Mannheim and 2 Department of Surgery Mannheim, University of Heidelberg, Heidelberg, 3 Department of Pediatrics, Dr. v. Haunersches Kinderspital, 4 Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany, and 5 Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois
Requests for reprints: Heike Allgayer, Department of Experimental Surgery/Molecular Oncology, Universitätsklinikum Mannheim, University of Heidelberg, 68167 Mannheim, Germany. Phone: 49-621-383-2226; Fax: 49-621-383-3809/1938; E-mail: DAllgayer{at}aol.com.
Purpose: Studies on the transactivation of genes via promoter elements have mostly been done on cell lines rather than resected tissues. This, however, is essential to address an in vivo or clinical relevance. We have previously shown tumor-specific binding of Sp1 and an activator protein (AP)-2related factor to promoter region 152/135 of the metastasis-related u-PAR gene in 60% of in vivoresected cancer tissues. Cell lines have implicated an additional role, and potential synergism, of an AP-1 region (190/171) in u-PAR regulation. This study was done to (a) analyze AP-1 binding to this region in resected tumor and normal tissues, and define subgroups in which it is tumor-specific, and (b) to analyze transcription factorbinding patterns to both promoter motifs in resected tissues, supporting synergism, and draw first prognostic conclusions.
Experimental Design: In 103 patients with colorectal cancer, electrophoretic mobility shift assay/supershift analysis for u-PAR promoter region 190/171 was done in tumors and normal tissues. In 71 patients, region 152/135 was also analyzed. U-PAR protein was measured by ELISA.
Results: Tumor-specific AP-1 binding to region 190/171 of the u-PAR promoter was found in 40% of patients. Subgroup analysis showed tumor-specific binding for c-Fos in 58%, for c-Jun in 50%, for JunD in 39%, and for Fra-1 in 4% of cases. AP-1 binding correlated significantly with u-PAR protein amounts in both normal and tumor tissues (P < 0.001), in contrast to a tumor-specific correlation with u-PAR of the AP-2/Sp1 region. In analyses for both promoter regions, 62% of cancers showed simultaneous binding for AP-1, AP-2, and Sp1, 11% for AP-1 and AP-2, 16% for AP-2 and Sp1, 4% for AP-2 only, 3% for AP-1 only, and 0% for Sp1 only. The binding of AP-1, AP-2, and Sp1 correlated significantly with each other (P < 0.001), the combination of AP-1 and AP-2 showing the highest correlation with u-PAR (P = 0.008). Preliminary survival analysis indicated a trend for poorer prognosis for binding of all three transcription factors.
Conclusion: This is the first study differentiating transcription factorbinding to two important u-PAR promoter regions in a large series of resected tumors and normal tissues. The AP-1 site seems to be a less tumor-specific regulator than the Sp1/AP-2 motif. Nevertheless, data corroborate the hypothesis of synergism between both elements in resected tumors.
This article has been cited by other articles:
![]() |
J. H. Leupold, I. Asangani, G. D. Maurer, E. Lengyel, S. Post, and H. Allgayer Src Induces Urokinase Receptor Gene Expression and Invasion/Intravasation via Activator Protein-1/p-c-Jun in Colorectal Cancer Mol. Cancer Res., May 1, 2007; 5(5): 485 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Maurer, J. H. Leupold, D. M. Schewe, T. Biller, R. E. Kates, H.-M. Hornung, U. Lau-Werner, S. Post, and H. Allgayer Analysis of Specific Transcriptional Regulators as Early Predictors of Independent Prognostic Relevance in Resected Colorectal Cancer Clin. Cancer Res., February 15, 2007; 13(4): 1123 - 1132. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |